Literature DB >> 2266131

Glycosaminoglycan-mediated leuserpin-2/thrombin interaction. Structure-function relationships.

H Ragg1, T Ulshöfer, J Gerewitz.   

Abstract

Two recently identified structural elements important for glycosaminoglycan-mediated activation of human leuserpin-2 (hLS2) were investigated in detail by functional analysis of variants secreted by transiently transfected COS cells. Highly specific requirements with respect to the nature of the involved amino acids as well as to their spatial arrangements were found to be crucial for efficient activation of hLS2 by dermatan sulfate. In contrast, binding and activation of hLS2 by heparin seem to be determined mainly by the positive charge density of the involved inhibitor segment. A dimeric repeat enriched in acidic amino acids turned out to exert a dual role with respect to structure and function of hLS2. First, in the absence of functional activators the negatively charged dimer interacts intramolecularly with the glycosaminoglycan-binding site. Second, the acidic dimer is instrumental in glycosaminoglycan-mediated activation of hLS2. The monomers constituting the acidic dimer are functionally not equivalent.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2266131

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Glycosaminoglycan-binding properties and kinetic characterization of human heparin cofactor II expressed in Escherichia coli.

Authors:  Suryakala Sarilla; Sally Y Habib; Douglas M Tollefsen; David B Friedman; Diana R Arnett; Ingrid M Verhamme
Journal:  Anal Biochem       Date:  2010-07-27       Impact factor: 3.365

2.  Fluorescent reporters of thrombin, heparin cofactor II, and heparin binding in a ternary complex.

Authors:  Ingrid M Verhamme
Journal:  Anal Biochem       Date:  2011-12-06       Impact factor: 3.365

Review 3.  Glycosaminoglycans and the regulation of blood coagulation.

Authors:  M C Bourin; U Lindahl
Journal:  Biochem J       Date:  1993-01-15       Impact factor: 3.857

4.  Characterization of the heparin-binding site of the protein z-dependent protease inhibitor.

Authors:  Likui Yang; Qiulan Ding; Xin Huang; Steven T Olson; Alireza R Rezaie
Journal:  Biochemistry       Date:  2012-05-02       Impact factor: 3.162

5.  A computational modeling and molecular dynamics study of the Michaelis complex of human protein Z-dependent protease inhibitor (ZPI) and factor Xa (FXa).

Authors:  Vasudevan Chandrasekaran; Chang Jun Lee; Ping Lin; Robert E Duke; Lee G Pedersen
Journal:  J Mol Model       Date:  2009-01-27       Impact factor: 1.810

6.  Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.

Authors:  E Ersdal-Badju; A Lu; X Peng; V Picard; P Zendehrouh; B Turk; I Björk; S T Olson; S C Bock
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Sucrose octasulfate selectively accelerates thrombin inactivation by heparin cofactor II.

Authors:  Suryakala Sarilla; Sally Y Habib; Dmitri V Kravtsov; Anton Matafonov; David Gailani; Ingrid M Verhamme
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

8.  Heparin Binds Lamprey Angiotensinogen and Promotes Thrombin Inhibition through a Template Mechanism.

Authors:  Hudie Wei; Haiyan Cai; Jiawei Wu; Zhenquan Wei; Fei Zhang; Xin Huang; Lina Ma; Lingling Feng; Ruoxi Zhang; Yunjie Wang; Hermann Ragg; Ying Zheng; Aiwu Zhou
Journal:  J Biol Chem       Date:  2016-09-28       Impact factor: 5.157

9.  Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion.

Authors:  Lina Ma; Jiawei Wu; Ying Zheng; Zimei Shu; Zhenquan Wei; Yinbiao Sun; Robin W Carrell; Aiwu Zhou
Journal:  Biomolecules       Date:  2020-05-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.